Prostate specific antigen adjusted for transition zone volume

Eiji Kikuchi, Jun Nakashima, Takashi Ohigashi, Hirotaka Asakura, Masaaki Tachibana, Masaru Murai

Cancer · 2000 · 59 citations · 29 references

Abstract

PSATZD had the most useful validity in the differentiation between prostate carcinoma and benign prostatic enlargement in the overall patient population and in patients with intermediate PSA levels.

References

29